Sanctuary Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.96M Buy
44,017
+27,331
+164% +$1.82M 0.01% 838
2026
Q1
$1.05M Buy
16,686
+5,844
+54% +$407K 0.01% 1308
2025
Q4
$720K Sell
10,842
-8,036
-43% -$520K ﹤0.01% 1503
2025
Q3
$1.27M Buy
18,878
+1,281
+7% +$101K 0.01% 1148
2025
Q2
$1.54M Buy
17,597
+10
+0.1% +$784 0.01% 971
2025
Q1
$1.2M Sell
17,587
-474
-3% -$38.7K 0.01% 1045
2024
Q4
$1.58M Buy
18,061
+3,226
+22% +$239K 0.01% 998
2024
Q3
$1.08M Buy
14,835
+3,615
+32% +$297K 0.01% 1215
2024
Q2
$1.4M Buy
+11,220
New +$1.42M 0.01% 1010

Other funds holding DXCM

Sanctuary Advisors's DXCM Position: Q2 2026 in Review

Sanctuary Advisors increased its DexCom (DXCM) stake by 164% in Q2 2026, buying an estimated $1.82M and bringing the position to 44,017 shares worth $2.96M. The position accounts for 0.01% of the portfolio, ranked #838.

Sanctuary Advisors first reported a position in DXCM in Q2 2024 and has held it in 9 quarters since. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Sanctuary Advisors held 44,017 shares of DexCom worth $2.96M as of Q2 2026.
  • Sanctuary Advisors bought 27,331 DexCom shares in Q2 2026, an estimated $1.82M.
  • DexCom made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #838 holding.
  • Sanctuary Advisors first reported a position in DexCom in Q2 2024 and has held it in 9 quarters since.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.